About the Magenta Study

The Study of Genetic Testing from Your Living Room.

The MAGENTA study aims to improve availability of genetic testing for hereditary cancer syndromes to at-risk individuals through the use of an online genetic testing service. Our hope is that making genetic testing accessible, without requiring them to travel to their healthcare provider, will save more lives by preventing cancer in women found to be at an increased risk of getting it.

Complete the eligibility questionnaire to find out if you are eligible for our study

Get Started

Data from the MAGENTA study will be collected and managed using REDCap (Research Electronic Data Capture), a secure, HIPAA compliant, web-based application with controlled access designed to support data captured from research studies.

Participation in this trial will not require any travel, but will require access to the internet and phone.

Study Requirements

Participants who qualify for this study will fill out personal and family health history information, undergo genetic testing (saliva sample) for 19 genes associated with inherited cancer risk, and complete a series of online questionnaires regarding their experience. Some individuals in this study will undergo genetic counseling over the phone; others not. For more information on study requirements, please review the MAGENTA Study Timeline below.

* The 19-gene panel includes: ATM, BARD1, BRCA1, BRCA2, BRIP1, CDH1, CHEK2, EPCAM, MSH2, MSH6, MLH1, NBN, PALB2, PMS2, PTEN, RAD51C, RAD51D, TP53, and STK11.

MAGENTA Study Timeline

Eligible Participants

The MAGENTA study will focus on women who:

Questions about the Study?

Email: magenta@mdanderson.org
Phone #: (713) 745-7877
Availability: Mon - Fri, 8am - 5pm CST

Media Inquiries

For all media inquiries, please contact Rebecca Lechner at (612) 822-0500 or via e-mail at rlechner@mnovarian.org.

A Collaborative Research Effort

The MAGENTA study is supported by the Stand Up To Cancer-Ovarian Cancer Research Fund Alliance-National Ovarian Cancer Coalition Dream Team .